Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies

Eur J Biochem. 2001 Jul;268(13):3685-93. doi: 10.1046/j.1432-1327.2001.02274.x.

Abstract

The crystal structure of the Fab fragment of the rat monoclonal antibody 198, with protective activity for the main immunogenic region of the human muscle acetylcholine receptor against the destructive action of myasthenic antibodies, has been determined and refined to 2.8 A resolution by X-ray crystallographic methods. The mouse anti-lysozyme Fab D1.3 was used as a search model in molecular replacement with the AMORE software. The complementarity determining regions (CDR)-L2, CDR-H1 and CDR-H2 belong to canonical groups. Loops CDR-L3, CDR-H2 and CDR-H3, which seem to make a major contribution to binding, were analyzed and residues of potential importance for antigen-binding are examined. The antigen-binding site was found to be a long crescent-shaped crevice. The structure should serve as a model in the rational design of very high affinity humanized mutants of Fab198, appropriate for therapeutic approaches in the model autoimmune disease myasthenia gravis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / pharmacology
  • Autoantibodies / immunology*
  • Binding Sites, Antibody
  • Computer Simulation
  • Crystallography, X-Ray / methods
  • Humans
  • Immunoglobulin Fab Fragments / chemistry*
  • Immunoglobulin Fab Fragments / pharmacology*
  • Mice
  • Models, Molecular
  • Molecular Sequence Data
  • Muramidase / immunology
  • Muscle, Skeletal / immunology
  • Myasthenia Gravis / immunology*
  • Protein Conformation
  • Protein Folding
  • Protein Structure, Secondary
  • Rats
  • Receptors, Nicotinic / chemistry*
  • Receptors, Nicotinic / immunology*
  • Software

Substances

  • Antibodies, Monoclonal
  • Autoantibodies
  • Immunoglobulin Fab Fragments
  • Receptors, Nicotinic
  • Muramidase